
Chicago, USA-based clinical research organization (CRO) Advanced Clinical which is providing full-service clinical development, functional service provider (FSP) solutions and strategic resourcing, has appointed John Cargill as chief commercial officer (CCO).
In his new role, Mr Cargill will lead Advanced Clinical’s global commercial strategy, focusing on expanding its presence across the pharmaceutical and biotechnology sectors, strengthening existing client relationships and identifying new growth opportunities across its integrated service portfolio.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze